These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31095959)

  • 1. Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.
    Snell JR; Kumar NSK; Suryanarayanan R; Randolph TW
    J Pharm Sci; 2020 Jan; 109(1):284-292. PubMed ID: 31095959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle Formation and Aggregation of a Therapeutic Protein in Nanobubble Suspensions.
    Snell JR; Zhou C; Carpenter JF; Randolph TW
    J Pharm Sci; 2016 Oct; 105(10):3057-3063. PubMed ID: 27488901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of Stable Nanobubbles on Reconstituting Lyophilized Formulations Containing Trehalose.
    Zhou C; Cleland D; Snell J; Qi W; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2249-53. PubMed ID: 27287517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannitol as an Excipient for Lyophilized Injectable Formulations.
    Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
    J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.
    Johnson RE; Kirchhoff CF; Gaud HT
    J Pharm Sci; 2002 Apr; 91(4):914-22. PubMed ID: 11948529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen storage of proteins: Use of mannitol to generate a homogenous freeze-concentrate.
    Sonje J; Chisholm CF; Suryanarayanan R
    Int J Pharm; 2023 Jan; 630():121995. PubMed ID: 35809832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
    Gitter JH; Geidobler R; Presser I; Winter G
    J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J; Schanda J; Friess W
    Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility.
    Jena S; Krishna Kumar NS; Aksan A; Suryanarayanan R
    Int J Pharm; 2019 Oct; 569():118568. PubMed ID: 31352055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Drying Time Reduction Using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.
    Gitter JH; Geidobler R; Presser I; Winter G
    J Pharm Sci; 2018 Oct; 107(10):2538-2543. PubMed ID: 29890173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage.
    Han Y; Jin BS; Lee SB; Sohn Y; Joung JW; Lee JH
    Arch Pharm Res; 2007 Sep; 30(9):1124-31. PubMed ID: 17958330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations.
    Roy S; Jung R; Kerwin BA; Randolph TW; Carpenter JF
    J Pharm Sci; 2005 Feb; 94(2):382-96. PubMed ID: 15614819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations.
    Kulkarni SS; Suryanarayanan R; Rinella JV; Bogner RH
    Eur J Pharm Biopharm; 2018 Oct; 131():70-81. PubMed ID: 30056143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
    Sonner C; Maa YF; Lee G
    J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.
    Hassett KJ; Cousins MC; Rabia LA; Chadwick CM; O'Hara JM; Nandi P; Brey RN; Mantis NJ; Carpenter JF; Randolph TW
    Eur J Pharm Biopharm; 2013 Oct; 85(2):279-86. PubMed ID: 23583494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
    Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
    Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.